📊 Analysis NASDAQ:BPMC : Financial Performance: 90% YoY growth in net-product revenues from U.S. sales of Ayvakit, a drug for certain cancers. Market Prospects: Positive market response to Ayvakit's unique clinical profile. CEO's Confidence: CEO's confidence in the company's future contributes to its momentum. 📈 Bullish Sentiment: Entry Range: Suggested entry...
This chart seems to love itself. Infatuated with its very own "Head and Shoulders" multiple times looking back on the daily! Waiting for this one to fill out completely before entering puts. No entry without confirmation. Inside channel, recent bounce off weekly resistance point forming its head. Will wait for pinbar to form on support level right where the...
Why get subbed to to me on Tradingview? -TOP author on TradingView -15+ years experience in markets -Professional chart break downs -Supply/Demand Zones -TD9 counts / combo review -Key S/R levels -No junk on my charts -Frequent updates -Covering FX/crypto/US stocks -24/7 uptime so constant updates BPMC: BUY DIPS 50% gains // SWING trade (STOCKS) IMPORTANT...
BPMC is printing a bullish full-body hammer candlestick over candlestick price bar on heavier above average volume with my momentum/trending oscillators confirming the price move. I am going long BPMC on Thursday using a limit (GTC-BUY-LMT) order @ 76.00. I will have one trailing sell stop (GTC-SELL-STP) @ 70.82 to protect my initial invested capital in case BPMC...